122 related articles for article (PubMed ID: 32150114)
1. TOPOGRAPHIC OPTICAL COHERENCE TOMOGRAPHY SEGMENTATION SHOWS LIMITED ELLIPSOID ZONE RECOVERY IN MILD HYDROXYCHLOROQUINE RETINOPATHY.
de Sisternes L; Pham BH; Durbin M; Marmor MF
Retin Cases Brief Rep; 2022 May; 16(3):263-269. PubMed ID: 32150114
[TBL] [Abstract][Full Text] [Related]
2. LONGITUDINAL CHANGES IN EYES WITH HYDROXYCHLOROQUINE RETINAL TOXICITY.
Allahdina AM; Chen KG; Alvarez JA; Wong WT; Chew EY; Cukras CA
Retina; 2019 Mar; 39(3):473-484. PubMed ID: 30741731
[TBL] [Abstract][Full Text] [Related]
3. En Face Optical Coherence Tomography Imaging of the Photoreceptor Layers in Hydroxychloroquine Retinopathy.
Ahn SJ; Joung J; Lee BR
Am J Ophthalmol; 2019 Mar; 199():71-81. PubMed ID: 30448463
[TBL] [Abstract][Full Text] [Related]
4. SEQUENTIAL RETINAL THICKNESS ANALYSIS SHOWS HYDROXYCHLOROQUINE DAMAGE BEFORE OTHER SCREENING TECHNIQUES.
Marmor MF; Durbin M; de Sisternes L; Pham BH
Retin Cases Brief Rep; 2021 May; 15(3):185-196. PubMed ID: 33394957
[TBL] [Abstract][Full Text] [Related]
5. Quantitative assessment of outer retinal layers and ellipsoid zone mapping in hydroxychloroquine retinopathy.
Ugwuegbu O; Uchida A; Singh RP; Beven L; Hu M; Kaiser S; Srivastava SK; Ehlers JP
Br J Ophthalmol; 2019 Jan; 103(1):3-7. PubMed ID: 30190364
[TBL] [Abstract][Full Text] [Related]
6. Effect of disease stage on progression of hydroxychloroquine retinopathy.
Marmor MF; Hu J
JAMA Ophthalmol; 2014 Sep; 132(9):1105-12. PubMed ID: 24922444
[TBL] [Abstract][Full Text] [Related]
7. Visual Field Sensitivity Prediction Using Optical Coherence Tomography Analysis in Hydroxychloroquine Toxicity.
Jayakar G; De Silva T; Cukras CA
Invest Ophthalmol Vis Sci; 2022 Jan; 63(1):15. PubMed ID: 35015028
[TBL] [Abstract][Full Text] [Related]
8. TOXIC EFFECTS OF HYDROXYCHLOROQUINE ON THE CHOROID: Evidence From Multimodal Imaging.
Ahn SJ; Ryu SJ; Lim HW; Lee BR
Retina; 2019 May; 39(5):1016-1026. PubMed ID: 29373341
[TBL] [Abstract][Full Text] [Related]
9. SEQUENTIAL CHANGES IN HYDROXYCHLOROQUINE RETINOPATHY UP TO 20 YEARS AFTER STOPPING THE DRUG: Implications for Mild Versus Severe Toxicity.
Pham BH; Marmor MF
Retina; 2019 Mar; 39(3):492-501. PubMed ID: 30550532
[TBL] [Abstract][Full Text] [Related]
10. Swept source optical coherence tomography angiography in patients treated with hydroxychloroquine: correlation with morphological and functional tests.
Forte R; Haulani H; Dyrda A; Jürgens I
Br J Ophthalmol; 2021 Sep; 105(9):1297-1301. PubMed ID: 30842084
[TBL] [Abstract][Full Text] [Related]
11. Long-Term Progression of Pericentral Hydroxychloroquine Retinopathy.
Ahn SJ; Seo EJ; Kim KE; Kim YJ; Lee BR; Kim JG; Yoon YH; Lee JY
Ophthalmology; 2021 Jun; 128(6):889-898. PubMed ID: 33129843
[TBL] [Abstract][Full Text] [Related]
12. Machine Learning-Based Automated Detection of Hydroxychloroquine Toxicity and Prediction of Future Toxicity Using Higher-Order OCT Biomarkers.
Kalra G; Talcott KE; Kaiser S; Ugwuegbu O; Hu M; Srivastava SK; Ehlers JP
Ophthalmol Retina; 2022 Dec; 6(12):1241-1252. PubMed ID: 35691579
[TBL] [Abstract][Full Text] [Related]
13. Disparity between visual fields and optical coherence tomography in hydroxychloroquine retinopathy.
Marmor MF; Melles RB
Ophthalmology; 2014 Jun; 121(6):1257-62. PubMed ID: 24439759
[TBL] [Abstract][Full Text] [Related]
14. Early hydroxychloroquine retinopathy: optical coherence tomography abnormalities preceding Humphrey visual field defects.
Garrity ST; Jung JY; Zambrowski O; Pichi F; Su D; Arya M; Waheed NK; Duker JS; Chetrit Y; Miserocchi E; Giuffrè C; Kaden TR; Querques G; Souied EH; Freund KB; Sarraf D
Br J Ophthalmol; 2019 Nov; 103(11):1600-1604. PubMed ID: 30819690
[TBL] [Abstract][Full Text] [Related]
15. Case Report: Hydroxychloroquine Retinopathy.
Eldeeb M; Chan EW; Omar A
Optom Vis Sci; 2018 Jun; 95(6):545-549. PubMed ID: 29787487
[TBL] [Abstract][Full Text] [Related]
16. Use of OCT Retinal Thickness Deviation Map for Hydroxychloroquine Retinopathy Screening.
Kim KE; Ahn SJ; Woo SJ; Park KH; Lee BR; Lee YK; Sung YK
Ophthalmology; 2021 Jan; 128(1):110-119. PubMed ID: 32553941
[TBL] [Abstract][Full Text] [Related]
17. Progression of hydroxychloroquine toxic effects after drug therapy cessation: new evidence from multimodal imaging.
Mititelu M; Wong BJ; Brenner M; Bryar PJ; Jampol LM; Fawzi AA
JAMA Ophthalmol; 2013 Sep; 131(9):1187-97. PubMed ID: 23887202
[TBL] [Abstract][Full Text] [Related]
18. Imaging of Hydroxychloroquine Toxicity with Fluorescence Lifetime Imaging Ophthalmoscopy.
Sauer L; Calvo CM; Vitale AS; Henrie N; Milliken CM; Bernstein PS
Ophthalmol Retina; 2019 Oct; 3(10):814-825. PubMed ID: 31345727
[TBL] [Abstract][Full Text] [Related]
19. Comparison of screening procedures in hydroxychloroquine toxicity.
Marmor MF
Arch Ophthalmol; 2012 Apr; 130(4):461-9. PubMed ID: 22159170
[TBL] [Abstract][Full Text] [Related]
20. Analysis of the outer retinal thickness pixel maps for the screening of hydroxychloroquine retinopathy.
Tarassoly K; Miraftabi A; Sedaghat A; Parvaresh MM
Int Ophthalmol; 2023 May; 43(5):1737-1743. PubMed ID: 36414851
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]